Total Payments
$2,557
2024 Payments
$503.85
Companies
31
Transactions
148
Medicare Patients
6,134
Medicare Billing
$605,817
Payment Breakdown by Category
Food & Beverage$2,557 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,557 | 148 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $380.12 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $346.85 | 20 | $0 (2024) |
| Lilly USA, LLC | $270.38 | 18 | $0 (2024) |
| ABBVIE INC. | $261.91 | 11 | $0 (2024) |
| Novo Nordisk Inc | $232.45 | 15 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $132.93 | 8 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $118.41 | 6 | $0 (2024) |
| Amgen Inc. | $100.11 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $79.27 | 5 | $0 (2024) |
| Abbott Laboratories | $74.71 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $503.85 | 26 | Lilly USA, LLC ($99.68) |
| 2023 | $666.86 | 34 | AstraZeneca Pharmaceuticals LP ($181.23) |
| 2022 | $385.99 | 22 | AstraZeneca Pharmaceuticals LP ($83.65) |
| 2021 | $296.38 | 18 | GlaxoSmithKline, LLC. ($56.82) |
| 2020 | $216.54 | 14 | Novo Nordisk Inc ($69.40) |
| 2019 | $221.43 | 16 | Novo Nordisk Inc ($49.27) |
| 2018 | $113.12 | 7 | SANOFI-AVENTIS U.S. LLC ($49.84) |
| 2017 | $153.29 | 11 | SANOFI-AVENTIS U.S. LLC ($54.92) |
All Payment Transactions
148 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Oncology | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: VACCINES | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: VACCINE | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes | ||||||
| 07/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Cardiovascular | ||||||
| 05/14/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardio-renal | ||||||
| 05/01/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $36.66 | General |
| Category: NEUROLOGY | ||||||
| 04/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardio-renal | ||||||
| 04/03/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 03/21/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: VACCINES | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Respiratory | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,140 | 7,657 | $836,739 | $264,615 |
| 2022 | 27 | 1,793 | 4,320 | $534,295 | $179,177 |
| 2021 | 21 | 1,086 | 1,567 | $251,167 | $92,036 |
| 2020 | 23 | 1,115 | 1,510 | $197,347 | $69,989 |
Total Patients
6,134
Total Services
15,054
Medicare Billing
$605,817
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 58 | 3,960 | $340,758 | $71,258 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 380 | 738 | $185,045 | $66,250 | 35.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 328 | 328 | $81,344 | $42,003 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 328 | 448 | $81,439 | $26,242 | 32.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 81 | 81 | $31,372 | $22,914 | 73.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 104 | 104 | $8,324 | $7,873 | 94.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 42 | 45 | $15,030 | $6,102 | 40.6% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 27 | 27 | $4,185 | $3,861 | 92.3% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 99 | 467 | $23,350 | $3,528 | 15.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 115 | 116 | $2,876 | $2,597 | 90.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 120 | 199 | $12,389 | $2,048 | 16.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 96 | 486 | $18,468 | $2,041 | 11.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 86 | 86 | $1,996 | $1,823 | 91.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 28 | 31 | $7,006 | $1,657 | 23.6% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 23 | 23 | $1,104 | $939.35 | 85.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 22 | 22 | $1,408 | $899.02 | 63.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 20 | $2,040 | $775.72 | 38.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 12 | $1,172 | $491.84 | 42.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 40 | 40 | $7,880 | $440.61 | 5.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 12 | 12 | $443.00 | $388.19 | 87.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 54 | 303 | $2,727 | $229.49 | 8.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 19 | 19 | $4,712 | $128.32 | 2.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 25 | 69 | $1,104 | $78.18 | 7.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 21 | $567.00 | $46.20 | 8.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 392 | 719 | $179,031 | $67,308 | 37.6% |
About Dr. Juli Ackerman, MD
Dr. Juli Ackerman, MD is a Internal Medicine healthcare provider based in Sheridan, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1619292927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juli Ackerman, MD has received a total of $2,557 in payments from pharmaceutical and medical device companies, with $503.85 received in 2024. These payments were reported across 148 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,557).
As a Medicare-enrolled provider, Ackerman has provided services to 6,134 Medicare beneficiaries, totaling 15,054 services with total Medicare billing of $605,817. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Sheridan, WY
- Active Since 03/30/2010
- Last Updated 10/17/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619292927
Products in Payments
- FARXIGA (Drug) $238.96
- VRAYLAR (Drug) $228.60
- TRELEGY ELLIPTA (Drug) $158.62
- MOUNJARO (Drug) $146.96
- SHINGRIX (Biological) $132.10
- Ozempic (Drug) $101.10
- JARDIANCE (Drug) $73.51
- Tresiba (Drug) $71.11
- UBRELVY (Drug) $66.92
- TOUJEO (Drug) $65.07
- SOLIQUA (Drug) $54.63
- OFEV (Drug) $52.49
- SPIRIVA RESPIMAT (Drug) $51.81
- Aimovig (Biological) $47.02
- XARELTO (Drug) $42.09
- ELIQUIS (Drug) $41.41
- Rybelsus (Drug) $38.17
- NEXPLANON (Drug) $38.03
- SUNOSI (Drug) $37.13
- INSPIRE (Device) $36.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sheridan
David Walker, Do, DO
Internal Medicine — Payments: $3,209
Internal Medicine $3,209
Dr. Hannah Hall, M.d, M.D
Internal Medicine — Payments: $2,546
Internal Medicine $2,546
Kristopher Schamber, M.d, M.D
Internal Medicine — Payments: $2,108
Internal Medicine $2,108
Benjamin Widener, M.d, M.D
Internal Medicine — Payments: $888.70
Internal Medicine $888.70
Sierra Gross, M.d, M.D
Internal Medicine — Payments: $710.86
Internal Medicine $710.86
Derek Redinger, Do, DO
Internal Medicine — Payments: $664.76
Internal Medicine $664.76